A critical element in the ability of endothelial NO to function in the vasculature is preventing its reaction with erythrocytic Hb (haemoglobin). Emerging concepts suggest that the biophysical and rheological properties of the red blood cell are important in meeting this criterion. It has been recognized for some time that cell-free Hb may react with endothelial NO and that this may underlie the problems with Hb-based blood substitutes. More recent data extend these concepts to haemolytic diseases, including sickle cell disease, and have also identified novel therapeutic strategies to prevent interactions of cell-free Hb with NO. In this overview we have hypothesized that production of high concentrations of NO can overcome the diffusional barriers presented by the red cell and result in formation of S-nitrosohaemoglobin. By doing so, it is hypothesized that Hb may mediate the vasodilatory potential of NO and contribute to the hypotensive responses observed in acute inflammatory diseases, including sepsis.
Introduction
Regulation of blood flow and vascular tone are among the original biological functions described for NO. The widely cited mechanism involves production of NO from the endothelial isoform of nitric oxide synthase, diffusion of NO to the underlying smooth muscle and subsequent activation of soluble guanylate cyclase and a signalling pathway that leads to vasodilation [1, 2] . NO is also important in anti-and pro-inflammatory processes in the vasculature which are important in development of disease. It is not surprising, then, that regulation of NO formation and reactivity is an important element of vascular homoeostasis mechanisms, elucidation of which will provide impor-tant insights into a variety of pathologies. An important and intriguing player in these mechanisms is Hb (haemoglobin), an erythrocytic protein that until recently was restricted to discussions in biochemistry classes as the archetypical model for an allosteric protein. In this short overview, we will discuss the recent insights that have revived interest in the biology of Hb from the perspective of how this haem protein impacts on the vascular functions of NO.
Oxygen and NO: comparison of the reactivity with Hb
The coupling of Hb's structural changes and functional capacity to reversibly bind small molecules including O 2 and CO 2 is one of the most extensively studied phenomena in biology. More recent insights suggest that similar principles apply to the interactions between NO and Hb and that these are critical in physiological regulation of blood flow [3, 4] . Before discussing these concepts in more detail however, the reactivities of NO and O 2 with Hb will be compared. In the case of O 2 , reversible binding of this molecule to the ferrous haem iron of Hb [forming oxyHb (oxyhaemoglobin)] varies in affinity as a function of the Hb structural or allosteric state and is the tenet upon which our understanding of O 2 delivery to respiring tissues is based ( Consideration of these reaction kinetics together with the relatively high ferrous haem concentrations (in the millimolar range) in the red blood cell compared with soluble guanylate cyclase levels present in the smooth muscle cell raised an important question: how does NO mediate vascular effects in the presence of a seemingly limitless sink? [7] Based on experimental and theoretical data, two concepts have emerged to explain NO bioactivity in the presence of Hb. The first is that compartmentalization of Hb in the red blood cell, coupled with the biophysical parameters of blood flow in a cylindrical chamber (i.e. the vessel wall), serve to limit reaction of NO and Hb. Secondly, Hb, via reversible interactions of NO with the haem and a specific thiol residue on the ␤-chain, serves to store and deliver NO to regions of low oxygen tensions. These concepts are now discussed in more detail.
Interactions of NO with erythrocytic Hb
The rate of the reaction between NO and erythrocytic Hb is significantly slowed (by approx. three orders of magnitude) compared with that with cellfree Hb. The general concepts proposed to explain these observations include the presence of diffusion barriers that impede movement of NO into the red blood cell. The proposed sources of these diffusional barriers include (i) unstirred layers present at the liquid-membrane interface, (ii) a submembrane protein matrix or (iii) the erythrocyte-free zone that is adjacent to the endothelium and formed as a consequence of blood flow [8] [9] [10] [11] [12] [13] [14] . The magnitude of this erythrocyte-free zone determines the quantity of NO that diffuses to the lumen of the blood vessel and is proportional to vessel diameter. The exact molecular mechanisms responsible for these effects remain unclear; however, increased scavenging of NO by O 2 in the hydrophobic compartment of lipid membranes has been demonstrated, supporting the idea of differences in NO availability depending on solvent characteristics and diffusional limitations [12] . However, these barriers are not present throughout the circulation (e.g. in the capillaries where red blood cells may directly interact with the endothelium) and NO can also be made in circulating cells (e.g. leucocytes), suggesting that the barriers discussed above are unlikely to completely prevent NO entering the red blood cell. This is demonstrated by detection of HbNO under physiological conditions in the venous circulation [15, 16] . Thus under physiological conditions a number of chemical and physical barriers limit NO produced in the endothelium from interacting with Hb in the red blood cell. As discussed below in the context of pathology this situation changes dramatically upon erythrocyte lysis, administration of cell-free Hb or formation of high concentrations of NO.
The SNOHb (S-nitrosohaemoglobin) hypothesis
A series of recent studies suggest that reactions with Hb are not limited to scavenging and inhibition of NO function (Table 1 , reaction 4), but can in fact lead to a stimulation of NO-dependent vasoactivity. Specifically, SNOHb, a derivative of Hb in which a cysteine residue (present at the 93rd position on the ␤-chains) is nitrosated, has been proposed to modulate NO-dependent regulation of blood flow in vivo [3, 4, [17] [18] [19] . In this hypothesis, the allosteric changes of O 2 binding and dissociation are coupled to alterations in the microenvironment of the Cys-␤93 residue such that, at low oxygen tensions, NO release and subsequent stimulation of vasodilation are promoted. The exact molecular mechanisms for this effect remain elusive but are absolutely dependent on reactions of SNOHb with other reduced thiols that may include glutathione or protein thiols of the red-blood-cell anion-exchanger protein. In this model, therefore, Hb is not only an O 2 transporter but also an O 2 sensor capable of controlling O 2 delivery via regulation of blood flow. Despite the elegance of this proposal, more recent studies conclude that SNOHb does not have a role in modulating physiological blood flow. Aspects of the SNOHb hypothesis that are disputed include mechanisms by which SNOHb is formed in vivo, vasodilatory mechanisms and kinetics of SNOHb S-nitrosation, concentrations of SNOHb in vivo and the role of oxygenation/deoxygenation of SNOHb in the vasodilation mechanisms. A detailed discussion of these ongoing controversies is beyond the scope of this short overview and the reader is referred to recent articles in this area [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] . Despite the many questions surrounding the physiological role of SNOHb, it is well established that SNOHb is capable of relaxing vessels in vitro, implying a functional ability of SNOHb to alter blood pressure. This concept will be pursued below from the perspective of pathological functions for Hb-NO interactions.
Hb and vascular pathology: interactions with NO
The pathological effects of Hb are thought to occur when this haem protein is outside the confines of the red blood cell. As discussed below, many studies have highlighted the potential of cell-free Hb to modulate vascular signalling mechanisms including NO-dependent pathways [6] . In addition, we suggest that erythrocytic Hb can also modulate pathological responses in the vasculture to NO, specifically during conditions that favour nitrosative chemistry and when NO production is elevated. Both of these scenarios are now discussed.
Cell-free haemoglobin
Free Hb can arise in the circulation during haemolysis or upon administration of Hb in experimental resuscitation fluids such as a Hb-based blood substitutes. Despite significant research efforts, clinical trials using a variety of cell-free Hbs have failed and in some cases even reported a detrimental effect of such compounds [30] . Cell-free Hb overcomes the diffusional obstacles presented by the red blood cell membrane and red blood cell-free zone and allows direct interaction between Hb, the endothelium and underlying tissue [10] . This is illustrated by vasospasm and hypertensive responses due to rapid scavenging of endothelium-derived NO [31, 32] . In addition, scavenging of NO by cell-free Hb has been shown to increase vascular permeability in the mesentery and modulate other vascular cell-signalling pathways including production of the vasoconstrictor, endothelin [33, 34] . Cell-free Hb is also a potent stimulator of oxidative reactions and collectively these factors may in part contribute to the limited success of cell-free Hbs as blood substitutes. The ability of cell-free Hb to disturb vascular homoeostatic mechanisms is emphasized by the existence of multiple potential defence mechanisms including haptoglobin (which binds cell-free Hb dimers), haemopexin (which binds haem released from cellfree Hb), haem oxygenase (which metabolizes haem) and ferritin (which chelates released iron).
More recently, a role for cell-free Hb-dependent inhibition of vascular NO function in haemolytic disorders has been demonstrated. Specifically, haemolysis during episodes of sickle cell crisis are thought to contribute to the pain and ischaemia associated with this disease [35] . Interestingly, treatment with inhaled NO has been shown to benefit patients during crisis due to NO reacting with Hb when it circulates to the lung. The mechanism for this therapeutic effect of NO inhalation is not thought to be due to increased delivery of NO to peripheral tissues but rather via reaction of NO with the cell-free oxyHb released during lysis to produce metHb and nitrate. MetHb is not capable of scavenging NO and thereby allows endothelium-derived NO to function normally in the periphery. Such studies highlight the potential impact of cell-free Hb to promote vascular dysfunction by inhibiting NO-dependent processes, and these considerations are likely to apply to other haemolytic disorders too.
Increased levels of NO and nitrosative chemistry
An unexplored area of potential significance by which Hb may modulate NO function in the vasculature is during increased synthesis of NO associated with acute inflammation as observed in sepsis. Sepsis is characterized by a systemic inflammatory response leading to high circulating levels of pro-inflammatory cytokines and activation of the inducible form of nitric oxide synthase [36] . High levels of inducible nitric oxide synthase-derived NO are thought to contribute to the marked hypotension and decreased tissue perfusion that leads to multi-organ failure and death. However, inhibitors of inducible nitric oxide synthase or scavengers of NO have variable effects on the disease [36] . The concept proposed herein is that Hb directs the function of NO under these inflammatory conditions. It is proposed that high levels of NO overcome the diffusional barriers discussed above and allow reaction with Hb in the red blood cell to occur via nitrosative chemistry that is associated with inflammation. The increased nitrosative stress experienced by the red blood cell exposed to high levels of NO during sepsis results in the modification of low-molecular-mass thiols and the formation of SNOHb. Consistent with this hypothesis, SNOHb levels increase from undetectable levels to micromolar concentrations in animal models of sepsis [37] . Although Hb may not serve as a NO storage pool under normal physiological conditions, SNOHb formed in sepsis may preserve NO bioactivity and contribute to dysregulation of haemodynamics that occurs in this disease. These concepts are currently being investigated and suggest that, during pathology, red blood cell lysis may not be a prerequisite to observe modulation of the vascular functions of NO by Hb.
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Summary
Identification of the biological targets and mechanisms of NO has been critical in understanding the vascular functions of this free radical. Just as important is understanding how NO avoids reactions with erythrocytic Hb. Diffusional barriers created by blood flow and the red blood cell membrane limit NO entry into the red blood cell ( Figure 1A ). In addition, SNOHb has been proposed to recycle NO and mediate physiological blood flow, although this proposition requires validation. The importance of preventing NO from reacting with Hb is illustrated by the effects of cell-free Hb, which results in hypertension. This may underlie episodes of pain and crisis experienced by patients with sickle cell disease and also the failure of Hb-based blood substi- Haemolysis or administration of cell-free Hb bypasses the diffusion barrier created by the red blood cell membrane and is not subject to flow-mediated separation from the endothelium. Under these conditions, Hb reacts rapidly with endothelial nitric oxide synthase-derived NO (solid arrow) and prevents activation of soluble guanylate cyclase (dashed arrow), causing hypertensive responses. (C) It is hypothesized that during conditions such as acute inflammation (as observed in sepsis) where NO is produced at high concentrations that favour nitrosative chemistry, NO can react with Hb in the red blood cell to form SNOHb, which then modulates hypotensive responses (dashed arrow).
tutes ( Figure 1B ). Proposed in this overview is the potential for NO to react with erythrocytic Hb during acute inflammation, where high concentrations (in the micromolar range) of NO are observed. It is hypothesized that this results in SNOHb formation, and in turn this mediates systemic hypotension observed in sepsis ( Figure 1C ).
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